Prescription drug · NDA AUTHORIZED GENERIC
fluvoxamine maleate NDC 50090-5988
Fluvoxamine maleate 100 mg/1 · Tablet, Coated · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-5988-0 | 50090598800 | 90 TABLET, COATED in 1 BOTTLE (50090-5988-0)Marketed from Jun 7, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- fluvoxamine maleate
- Generic name (nonproprietary)
- fluvoxamine maleate
- Active ingredients
- Fluvoxamine maleate — 100 mg/1
- Dosage form
- Tablet, Coated
- Route
- Oral
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 021519
- Marketing start
- Listing expires
- Other FDA classes
- Serotonin Uptake Inhibitors (Mechanism)
- Identifiers
- Product ID 50090-5988_332c1d1a-54e7-490b-afbf-2c005a86c788SPL ID 332c1d1a-54e7-490b-afbf-2c005a86c788SPL set ID ddc9e7e8-f041-43bb-970b-cd4b30367637RxCUI 903884UNII 5LGN83G74V
- Pharmacologic class
- Serotonin Reuptake Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090598800followed by a unit qualifier and the quantityPackage 50090-5988-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Fluvoxamine Maleate Tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD) ( 1 ). 1.1 Obsessive-Compulsive Disorder Fluvoxamine Maleate Tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD), as defined in DSM-III-R or DSM-IV. The obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning. Obsessive compulsive disorder is characterized by recurrent and persistent ideas, thoughts, impulses or images (obsessions) that are ego-dystonic and/or repetitive, purposeful, and intentional beh…
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 021519
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| fluvoxamine maleate | Fluvoxamine maleate 50 mg/1 | Tablet, CoatedOral | ANI Pharmaceuticals, Inc. | 62559-159 |
| fluvoxamine maleate | Fluvoxamine maleate 25 mg/1 | Tablet, CoatedOral | ANI Pharmaceuticals, Inc. | 62559-158 |
| fluvoxamine maleate | Fluvoxamine maleate 100 mg/1 | Tablet, CoatedOral | ANI Pharmaceuticals, Inc. | 62559-160 |
| fluvoxamine maleate | Fluvoxamine maleate 100 mg/1 | Tablet, CoatedOral | Preferred Pharmaceuticals, Inc. | 68788-7219 |
| fluvoxamine maleate | Fluvoxamine maleate 100 mg/1 | Tablet, CoatedOral | REMEDYREPACK INC. | 70518-1057 |
| fluvoxamine maleate | Fluvoxamine maleate 50 mg/1 | Tablet, CoatedOral | REMEDYREPACK INC. | 70518-1643 |